More than $250 million in cannabis sales reported since Minnesota launched recreational market
The Minnesota Office of Cannabis Management has revealed that $250 million was spent on cannabis products in the state in the year since adult-use dispensaries began operating.
Minnesota cannabis sales hit $250 million in first year
Minnesotans have purchased more than $250 million worth of cannabis products since the state launched the licensed business market a year ago.
Trump’s marijuana rescheduling push is back in focus. Is Tilray stock finally a buy?
The Tilray bull case is getting stronger without U.S. legalization.
OCR Reminds Applicants of Sept. 15 Cannabis License Deadline
With the deadline just one day away, the Virgin Islands Office of Cannabis Regulation is reminding prospective cannabis business owners to complete applications for several available licenses by …
Opening the Door to Social Consumption: Massachusetts’ Next Chapter in Cannabis Regulation
The state’s regulations are here, but the rollout largely depends on municipal and operational barriers that may slow or frustrate implementation.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Canopy Growth’s Business Is Improving. So Why Isn’t the Stock Performing Better?
Most of this came from at-the-market (ATM) equity program sales of newly issued stock in mid-2025. A separate ATM program, authorized in August 2025, gives it the right to raise another $200 million.
Curaleaf’s hostile takeover bid for Aurora is just the tip of the iceberg for cannabis consolidation. These 2 stocks could be the biggest winners
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.
5 Best Cannabis ETFs for 2026 and How to Invest
Discover the best marijuana ETFs to invest in, offering diversified exposure to the cannabis industry with growth potential and reduced risk.
Why Rescheduling Might Not Move Canopy Growth’s Stock as Much as You Think
Canopy Growth is a marijuana stock, but U.S. regulations aren’t the main driver of its business.
CbdMD Enters Definitive Agreement To Acquire Twinlab Brands To Expand Wellness Platform; Stock Up
(YCBD), a consumer wellness company, announced that it has entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, …
Black Tie CBD Introduces Expert-Curated BudTender’s Choice THCA Flower Program
BROWNS SUMMIT, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) — Black Tie CBD today introduced its new BudTender’s Choice program, combining Certified Ganjier recommendations with flexible subscription options …
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo’s Optimized …
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses …
Will NYSE Composite Cannabis Stocks Extend Gains After CBD Shift?
Cannabis sector developments and NYSE Composite discussions intensified after federal CBD enforcement changes, highlighting hemp-derived products, wellness markets, and evolving regulatory frameworks.
TLRY stock back into the limelight – a look at the key developments that sparked investor optimism
The DEA rescheduling hearing that could reclassify marijuana is expected to be held on June 29. ・On Thursday, the Trump Administration pushed Congress to keep hemp CBD products legal by amending the …
Recent Comments